Life Science News

Universal Ibogaine Inc. a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021 . Dr Ian Rabb Dr Ian Rabb is one of the most recognized and respected leaders in Addiction Treatment ...

Universal Ibogaine Inc. (TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021 .

Dr Ian Rabb

Dr Ian Rabb is one of the most recognized and respected leaders in Addiction Treatment in Canada today.  Dr. Ian Rabb is a certified Interventionist and addictions specialist who has helped thousands of people overcome addiction. In his 20 years of sobriety, he has founded Two Ten Recovery and Destiny House Winnipeg's only sober living housing organization.  Ian was the visionary founding member of Aurora Recover Centre in Gimli Manitoba and most recently held the position of Director of Business Development at Edgewood Health Network, Canada's only national addiction treatment center brand.  Prior to his work in addiction treatment Ian was a practicing Doctor of Optometry.

Ian has served on the board of directors of the Addictions Foundation of Manitoba and Tamarack Rehab.  He was Chair of a forum for VOICES, which provides healthy, welcoming community centers where transitioning foster youth and adults can have access to comprehensive housing, education, employment, and wellness services. Ian served on the inaugural board of End Homelessness Winnipeg and sat on the Community Advisory Board for federal The Homelessness Partnering Strategy.  Ian was also appointed to a federal, provincial and municipal illicit drug task force in 2019. He has further played an active role on the board of the Jewish Child and Family Services and performed fund raising roles for the Children's Hospital Foundation, and the Health Science Centre Foundation.  Ian was nominated as a finalist for the national Scotiabank Game Changers (celebrating local heroes) in 2012; was awarded the Queens Diamond Jubilee medal in 2012; and in 2016, Ian was chosen and honoured as a "Manitoba Hero" for his tireless work in service of Manitobans.

In his own words Ian says "In my 20 years in the addiction recovery business I have not seen anything that has the power of Ibogaine to disrupt the devastating effects of addiction and help change the course of peoples lives who have been living with addiction.  The opportunity to join the leadership of Universal Ibogaine, to guide in their mission to advance the science of addiction treatment to a level we have never seen before provided an opportunity to be of service that I could not refuse.  I am so grateful for the opportunity to lead the clinic operations and development area of Universal Ibogaine."

Dr Rami Batal CEO of Universal Ibogaine shared his enthusiasm for this significant addition to the team "Universal Ibogaine has two main pillars of business: the development of medicines for addiction with the medicalization of ibogaine being a central feature, and the development of state-of-the-art holistic addiction treatment centers.  Today we have taken a significant step forward in the realization of best-in-class holistic treatment for addiction.  With our recent operating clinic acquisition and the addition of Ian to the leadership team we are confidently moving towards our goal of creating the gold standard for addiction treatment.  We intend to optimize the treatment program at our Kelburn facility then roll out in future clinics, directly or through partnerships in Canada , USA and Internationally."

Dr Alberto Sola Co-Founder of Universal Ibogaine indicated "We know ibogaine works to disrupt addition and facilitate rapid and relatively pain free detox from opioids and other drugs.  As we work through the regulatory process with Health Canada, we can develop a best-in-class holistic long-term disease management model, customized to the needs of the individual.  The protocol will be based first on conventional detox and treatment, then using ibogaine as it becomes approved.  There is no one more experienced or competent in that program development than Dr Ian Rabb ."

Kelburn Mental Health and Addiction Treatment Facility
Dr Ian Rabb will take the helm at the Universal Ibogaines recently acquired addiction treatment facility located outside of Winnipeg , Manitoba.  Ian's first step will be to add conventional medical detox into the treatment offering at Kelburn.  Next, he aims to develop innovative, unique individualized treatment programs with a menu of post detox treatment modalities including various psychotherapy models, evidence based nuevo treatments that can include other plants medicines, nutrition, exercise, and time in nature facilitated by Kelburn's pristine natural setting.  From there Ian looks to incorporate indigenous wisdom and healing facilitated by local first nations leaders.

About Universal Ibogaine Inc.

UI is a life sciences company, with a goal to develop a platform of addiction treatment clinics, which may eventually use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants.

UI separately plans to clinically develop ibogaine, a natural plant substance, as an authorized addiction interruption medicine for the treatment of Opioid Use Disorder.  A Clinical Trial Application to Health Canada is being developed to undertake clinical trials in Canada , aimed at proving the safety and efficacy of the use of ibogaine for this purpose.  In the longer term, UI plans to introduce ibogaine into the addiction treatment protocols to be used in its' future facilities.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

‎This news release may contain forward-looking statements and information. Forward-looking information is frequently characterized by words such ‎as "plans", "expect", "project", "intend", "will", "believe", "anticipate", "estimate", "scheduled", ‎‎"potential", or other similar words, or statements that certain events or conditions "may", "should" or ‎‎"could" occur.  The forward-looking statements and information are based on certain key expectations ‎and assumptions made by UI.  Although UI believes that the expectations and assumptions on which the forward-‎looking statements are based are reasonable, undue reliance should not be placed on the forward-‎looking statements because UI can give no assurance that they will prove to be correct.

Since ‎forward-looking statements address future events and conditions, by their very nature they involve ‎inherent risks and uncertainties. Actual results could differ materially from those currently anticipated ‎due to a number of factors and risks, which include, but are not limited to, risks that required ‎regulatory approvals are not obtained. The reader is cautioned that assumptions used in the ‎preparation of such information, although considered reasonable by UI at the time of ‎preparation, may prove to be incorrect and readers are cautioned not to place undue reliance on ‎forward-looking information, which speaks only to conditions as of the date hereof.  UI does not ‎undertake any obligation to release publicly any revisions to forward-looking information contained ‎herein to reflect events or circumstances that occur after the date hereof or to reflect the occurrence ‎of unanticipated events, except as may be required under applicable securities laws. ‎

Related Links

https://universalibogaine.com

SOURCE Universal Ibogaine Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2021/04/c9015.html

News Provided by Canada Newswire via QuoteMedia

Universal Ibogaine

Universal Ibogaine

Keep reading... Show less
Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities

Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities

Kelburn Recovery Centre is pleased to announce that Dr. Ian Rabb addiction treatment and clinic operations veteran has recently joined as Managing Director.

Dr Ian Rabb recently named Chief Clinics Officer for Universal Ibogaine Inc ((TSXV: IBO), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, effective November 15 th 2021.  Universal Ibogaine acquired the Kelburn Clinic in October of 2021.

Keep reading... Show less
UNIVERSAL IBOGAINE ANNOUNCES WORLD-CLASS CLINICAL TRIAL PARTNERS IN ADVANCE OF CLINICAL TRIAL APPLICATION FOR IBOGAINE IN OPIOID USE DISORDER

UNIVERSAL IBOGAINE ANNOUNCES WORLD-CLASS CLINICAL TRIAL PARTNERS IN ADVANCE OF CLINICAL TRIAL APPLICATION FOR IBOGAINE IN OPIOID USE DISORDER

Universal Ibogaine Inc. (TSXV: IBO) (" UI " or the " Company ") a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, is pleased to introduce its contract research organization ("CRO") partners who will enable UI's planned clinical trial in Canada to be conducted, subject to the required approval by Health Canada. UI is currently working with its CRO partners to finalize UI's study design in advance of an anticipated pre-clinical trial application meeting to soon be held with Health Canada.

Keep reading... Show less
The Power Play by The Market Herald Releases Interviews With Reyna Gold, Universal Ibogaine, NewRange Gold, Fabled Copper, and Fandom Sports Media

The Power Play by The Market Herald Releases Interviews With Reyna Gold, Universal Ibogaine, NewRange Gold, Fabled Copper, and Fandom Sports Media

The Power Play by The Market Herald has announced the release of new interviews with Reyna Gold, Universal Ibogaine, NewRange Gold, Fabled Copper, and Fandom Sports Media discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less
Micron Technologies Sympathizes with the Worldwide Wave of the Omicron Covid Variant and Offers Medical Grade Face Masks

Micron Technologies Sympathizes with the Worldwide Wave of the Omicron Covid Variant and Offers Medical Grade Face Masks


Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company"), through its medical face mask manufacturing subsidiary, Micron Technologies Inc. ("Micron Technologies"), sympathizes with the worldwide wave of the Omicron Covid variant and urges its clients to utilize medical grade face masks in any social settings.

Corporate Video:

https://cdn.shopify.com/s/files/1/0492/9627/7672/files/Micron-Commercial.mp4?v=1641791344

Products

Micron Technologies has been operating at its facility in Delta, British Columbia, since August 2020, where it manufactures medical grade face masks under its Medical Device Establishment License issued by Health Canada. Micron Technologies is also registered with the US Food and Drug Administration. The Company's product line focuses on three key product lines:

  1. three ply medical grade face masks, which conform to ASTM F2100 Medical Grade Level 3 standards;
  1. N95 Model 8800 face masks, which have been approved by Health Canada and the US Food and Drug Administration; and
  1. face mask filters.

Available on Amazon, Shopify, and at Walmart

Micron Technologies' three-ply medical grade face masks and N95 Model 8800 face masks are available for purchase on Amazon, Shopify, and at Walmart. Face masks can also be purchased directly from Micron Technologies at https://micronti.com/pages/micron-video

About Beyond Medical

Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company, through its subsidiary Micron Technologies, manufactures medical grade face masks. The Company also has an investment in digital telehealth platform in Kayan Health. Kayan Health is an artificial-intelligence powered health communications platform that allows doctors to communicate with their patients and monitor them remotely. https://kayanhealth.com

Kal Malhi, CEO
604-805-4602
kal@bullruncapital.ca

The Company is not making any express or implied claims that its products have the ability to eliminate, cure or contain COVID-19 (or SARS-2 Coronavirus) at this time.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

FORWARD LOOKING STATEMENTS:

This news release includes certain statements that may be deemed "forward-looking statements". All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109477

News Provided by Newsfile via QuoteMedia

Universal Ibogaine Announces Change in Leadership

Universal Ibogaine Announces Change in Leadership

(TheNewswire)

Universal Ibogaine Inc.

Universal Ibogaine Inc. (TSXV:IBO) ("UI" or the "Company") announces that Rami Batal has been replaced as Chief Executive Officer ("CEO") of the Company and its subsidiaries. For the present time, the Company has appointed Nick Karos as CEO, effective immediately. Mr. Karos had recently been appointed as a Capital Markets consultant to the Company

Keep reading... Show less
Cloud DX

Cloud DX

Overview

The COVID-19 global pandemic shook traditional healthcare structures on a global scale in 2020. There has been an urgent need for integrated systems to manage the influx of patients and new social distancing measures, which forced many to delay seeking in-person medical attention. In identifying this gap in the healthcare system, digitally driven telemedicine companies are leading the way to innovate and improve healthcare for all in this increasingly digital age.

By 2022, the global healthcare market is forecasted to grow to US$11.9 trillion, with the digital healthcare sector to grow by a projected compound annual growth rate (CAGR) of 38 percent by 2026. In dealing with the aftermath of this pandemic, investing in healthcare and wellness technology is investing in the healthcare systems we’ve needed for a long time.

Keep reading... Show less

Latest Press Releases

Related News

×